Iteos Therapeutics Correlations

ITOS Stock

USD 8.54 0.35 4.27%

The current 90-days correlation between Iteos Therapeutics and Mirati Ther is 0.03 (i.e., Significant diversification). The correlation of Iteos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Iteos Therapeutics Correlation With Market

Modest diversification

The correlation between Iteos Therapeutics and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iteos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Iteos Stock please use our How to Invest in Iteos Therapeutics guide.

Moving together with Iteos Stock

0.69	ELAN	Elanco Animal Health Potential Growth	Pair Corr
0.66	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.61	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.73	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.69	RDY	Dr Reddys Laboratories	Pair Corr
0.73	TAK	Takeda Pharmaceutical	Pair Corr
0.63	INMB	INmune Bio	Pair Corr
0.68	REVB	Revelation Biosciences	Pair Corr
0.76	SIGA	SIGA Technologies	Pair Corr

Moving against Iteos Stock

0.88	EWTX	Edgewise Therapeutics	Pair Corr
0.88	BHC	Bausch Health Companies	Pair Corr
0.79	GILD	Gilead Sciences	Pair Corr
0.74	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.69	GANX	Gain Therapeutics	Pair Corr
0.61	ESPR	Esperion Therapeutics	Pair Corr
0.49	WAT	Waters	Pair Corr
0.41	EBS	Emergent Biosolutions	Pair Corr
0.41	HCM	HUTCHMED DRC	Pair Corr
0.35	BCTXW	BriaCell Therapeutics	Pair Corr
0.34	VTRS	Viatris	Pair Corr
0.34	BFRIW	Biofrontera Warrants	Pair Corr
0.75	BSX	Boston Scientific Corp	Pair Corr
0.54	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.35	ABT	Abbott Laboratories Fiscal Year End 22nd of January 2025	Pair Corr
0.34	DXCM	DexCom Inc	Pair Corr
0.33	MNMD	Mind Medicine	Pair Corr

Related Correlations Analysis

	ICVX	MRTX	VECT	ANNX	GRCL	THRX	GLUE	DSGN	ERAS	APLS
ICVX		-0.59	0.76	0.39	0.74	-0.35	0.2	0.31	-0.38	-0.93	ICVX
MRTX	-0.59		-0.75	0.04	-0.75	0.73	-0.46	-0.17	0.19	0.55	MRTX
VECT	0.76	-0.75		0.33	0.92	-0.45	0.56	0.57	-0.02	-0.73	VECT
ANNX	0.39	0.04	0.33		0.27	0.47	-0.07	0.18	0.11	-0.37	ANNX
GRCL	0.74	-0.75	0.92	0.27		-0.46	0.4	0.49	-0.17	-0.73	GRCL
THRX	-0.35	0.73	-0.45	0.47	-0.46		-0.34	-0.05	0.28	0.3	THRX
GLUE	0.2	-0.46	0.56	-0.07	0.4	-0.34		0.52	0.39	-0.13	GLUE
DSGN	0.31	-0.17	0.57	0.18	0.49	-0.05	0.52		0.39	-0.24	DSGN
ERAS	-0.38	0.19	-0.02	0.11	-0.17	0.28	0.39	0.39		0.48	ERAS
APLS	-0.93	0.55	-0.73	-0.37	-0.73	0.3	-0.13	-0.24	0.48		APLS
	ICVX	MRTX	VECT	ANNX	GRCL	THRX	GLUE	DSGN	ERAS	APLS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GRCL	+ 0.92	VECT
VECT	+ 0.76	ICVX
GRCL	+ 0.74	ICVX
THRX	+ 0.73	MRTX
DSGN	+ 0.57	VECT
GLUE	+ 0.56	VECT

High negative correlations

APLS	- 0.93	ICVX
GRCL	- 0.75	MRTX
VECT	- 0.75	MRTX
APLS	- 0.73	GRCL
APLS	- 0.73	VECT
MRTX	- 0.59	ICVX

Risk-Adjusted Indicators

There is a big difference between Iteos Stock performing well and Iteos Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iteos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ICVX	4.87	0.93	0.17	1.58	4.56	(5.67)	10.22	(6.79)	38.57
MRTX	2.24	(0.50)	0.00	(0.67)	0.00	0.00	4.02	(4.07)	16.13
VECT	2.63	0.98	0.54	0.96	0.88	(3.64)	5.61	(3.08)	39.30
ANNX	2.57	(0.34)	0.00	(0.08)	0.00	0.00	6.98	(5.26)	23.00
GRCL	5.71	1.16	0.18	0.62	6.35	(6.70)	16.34	(6.25)	52.11
THRX	5.44	(0.66)	0.00	(0.61)	0.00	0.00	11.75	(8.57)	90.33
GLUE	4.99	0.61	0.18	0.32	3.86	(6.77)	7.42	(8.18)	102.66
DSGN	3.98	0.16	0.06	0.18	5.14	(4.42)	9.43	(7.45)	35.31
ERAS	3.24	(0.04)	0.02	0.09	3.55	(3.75)	7.34	(5.19)	17.38
APLS	2.51	(0.25)	0.00	(0.26)	0.00	0.00	4.48	(5.17)	15.97

Iteos Therapeutics Corporate Management

Matthew Gall	Chief Officer	Profile
Matthew MBA	Chief Officer	Profile
Ryan Baker	Head Relations	Profile
Joanne MD	Chief Officer	Profile
Adi Osovsky	Executive Legal	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC